‹ ›
MYP_057265
← PREVIOUS NEXT → BACK
Basic Information
Unnamed
Antimicrobial
Antiviral
Antiviral ▸ Anti-HIV
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition ▸ Fusion inhibitor
Standard
36 amino acids
C184H310N56O51
Standard
Sequence
SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL
Physicochemical Analysis
4122.77 Da
10.83
1.55
1.29
0.0430
0.02
0.57
0.07
61.04
143.61
0.0278
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1784.77
-16.03
59.0
54.0
144.0
291.0
3.0
45.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0269058 VERIFIED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
HIV gp41 HR1 fusion inhibitor
32630.0
Structure & Mods
synthetic linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Antiviral Anti-HIV Fusion inhibitor
HIV
PaperAntiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides Evidence URLhttps://patents.google.com/patent/US7556813B2/en PatentUS 7556813 B2
RECORD: Rec_0384935 VERIFIED: YES
Provenance & Taxonomy
Human immunodeficiency virus 1 [Virus]
11676
Structure & Mods
branched peptide architecture [Branched]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Fusion inhibitor
293T
7 μM
IC50
PaperTrimeric, coiled-coil extension on peptide fusion inhibitor of HIV-1 influences selection of resistance pathways. PMID22235115 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/22235115/
FIRST PREV 1 2
Showing 2 records on this page · Page 2 of 2